The new RNA Therapeutics Institute (RTI), co-directed by Craig Mello, Victor Ambros, Melissa Moore, and Phillip Zamore, invites applications for tenure-track positions in the areas of RNA BIOLOGY and RNA-BASED THERAPY. Successful candidates will conduct innovative research aimed at understanding fundamental biological mechanisms involving RNA, and/or developing novel nucleic acid-based human therapeutics.

Areas of specific interest include (but are not limited to): genetics and biochemistry (in model organisms, pre-clinical models, and human disease) of regulatory RNAs, non-coding RNAs and RNA-protein complexes; chemical biology of RNA-mediated cellular processes; engineering of nucleic acids for controlled delivery and improved efficacy in vivo.

The RTI will be housed in a new state-of-the-art research building, and is part of a major campus-wide initiative in RNA therapeutics, stem cell biology and gene therapy that is designed to promote collaboration among basic scientists, preclinical investigators and clinicians. To further foster collaboration, RTI investigators will hold joint appointments with other departments on campus.

Applicants should submit a cover letter, curriculum vitae, statement of research interests and contact information for three references to http://www.academicjobsonline.org. Applications will be reviewed expeditiously, with interviews commencing in November. Inquiries, but not application materials, may be directed to Phillip Zamore (phillip.zamore@umassmed.edu). Applications from both junior level and more senior researchers will be considered.

As an equal opportunity and affirmative action employer, UMMS recognizes the power of a diverse community and encourages applications from individuals with varied experiences, perspectives and backgrounds.